Dainippon Sumitomo Pharma Co., Ltd. (DSP) and Nippon Shinyaku Co., Ltd. Announce they have concluded a license agreement for exclusive rights to develop, manufacture and commercialize SMP-986 in Japan, a new therapeutic agent for overactive bladder created by DSP.
Showing posts with label Nippon Shinyaku. Show all posts
Showing posts with label Nippon Shinyaku. Show all posts
Subscribe to:
Posts (Atom)